Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2002-12-04
2009-12-08
Minnifield, N. M (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C424S246100, C424S093460, C424S093100, C424S093400, C424S184100, C424S278100
Reexamination Certificate
active
07628982
ABSTRACT:
Disclosed is a composition for administration to a human or animal subject, the composition containing spores ofBacillus subtilisin an amount effective to stimulate immune responsiveness in the subject. The spores have an adjuvant, immunomodulatory, immune potentiation, or dendritic cell maturation effect, or a combination thereof Also disclosed is a method of boosting an immune response in an animal subject by administeringB. subtilisspores to an animal or human subject. Further disclosed is a vaccine containingB. subtilisspores, in the presence or absence of an antigen.
REFERENCES:
patent: 5800821 (1998-09-01), Acheson et al.
patent: 2002/0150594 (2002-10-01), Goldman et al.
patent: 2003/0147923 (2003-08-01), Klaviniskis et al.
patent: 2 370 772 (2002-07-01), None
patent: WO 02/00232 (2002-01-01), None
patent: WO 03/055513 (2003-07-01), None
patent: WO 03/074682 (2003-09-01), None
Welkos et al, Microbial Pathogenesis, 1988, 5:127-139.
Duc et al, Expert Opinion Biol. Ther., 2003, 3/8:1263-1270.
Cutting, In: Bacterial Spore Formers, editors Ricca et al, 2004, pp. 201-206.
Himanen et al, Vaccine, 1993, 11/9:970-973.
Saris et al, FEMS Microbiology Letters, 1990, 68:143-148.
Ivins et al, Infection and Immunity, 1986, 54/2:537-542.
Gregoriadis, Immunomethods, 1994, 4:210-216.
Acheson et al, Vaccines 97, 1997, pp. 179-184.
Barnes et al, Current Opinion in Molecular Therapeutics, 2000, 2/1:87-93.
Gursel et al, Drug Targeting and Delivery, 1995, 6:35-50.
Idanpaan-Heikkila et al, Vaccine. 1996, 14/9:886-891.
Muttilianen et al, Microbial Pathogenesis, 1995, 18:365-371.
Duc et al, Infection and Immunity, 2003, 71/5:2810-2818.
Ivins et al, Infection and Immunity, 1990, 58/2:303-308.
Gregoriadis et al, Methods, 1999, 19:156-162.
Baillie et al, FEMS Microbiology Letters, 1998, 163:43-47.
Oggioni et al, Vaccine, 2003, 21:S2/96-S2/101.
Duc et al, Vaccine, 2003, 21:4215-4224.
Mauriello et al, Vaccine, 2004, 22:1177-1187.
Duc et al, Vaccine, 2004, 22:1873-1885.
Ciabattini et al, Vaccine, 2004, 22:4139-4143.
Atrih et al, J. Bacteriology, Sep. 1998, 180/17:4603-4612.
Nicholson et al, Microbiology and Molecular Biology Reviews, Sep. 2000, 64/3:548-572.
Novelli et al, Chemioterapia, Jun. 1984, 3/3:152-155.
Clark Burton et al, J. Environmental Monitoring, 2005, 7/5:475-480.
Gialdroni-Grassi et al, Int. Archs. Allergy Appl. Immunol., 1985, 76/Suppl. 1:119-127.
Isticato et al, J. Bacteriology, Nov. 2001, 183/21:6294-6301.
Uyen et al, Vaccine, 2007, 25:356-365.
Paccez et al, Vaccine, 2006, 24:2935-2943.
Duc et al, Vaccine, 2007, 25:346-355.
Zhou et al, Vaccine, 2008, 26:1817-1825.
Buchanan, J. Bacteriology, Nov. 1987, 169/11:5301-5303.
Folmsbee et al, Applied and Environmental Microbiology, Sep. 2004, 70/9:5252-5257.
Shaver et al, Molecular Microbiology, 2001, 42/1:101-109.
Banchereau et al. 2000. Immunobiology of dendritic cells.Ann Rev Immunol. 18:767-811.
Ben-Yedidia et al.. 1998. Efficacy of anti-influenza peptide vaccine in aged mice.Mech. Aging Dev. 104(1):11-23.
Bluestone J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation.Immunity. 2(6):555-9.
Caruso et al. 1993. Expression of activation markers on peripheral blood lymphocytes following oral administration ofBacillus subtilisspores.Int J. Immunopharmac. 15:87-92.
Chambers C, 2001. The expanding world of co-stimulation: the two signal model revisited.Trends in Imunol. 22:217-223.
Chintalacharuvu et al. 2001. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.Clin Exp Immunol. 126(2):326-333.
Cipriandi et al. 1986a. Effects of an adjunctive treatment withBacillus subtilisfor food allergy.Chemoterapia. 5: 408-410.
Cipriandi et al.. 1986b. In vitro effects ofBacilus subtilison the immune response.Chemoterapia. 5:404-407.
Cohn, F. 1872. “Untersuchungen uber Bakterien.” Beitrage zur Biologie der Pflanzen, 1875 1 (Heft 2) 1:127-224.
Danengerg et al. 1997. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects.J. Clin Endroclinol Metab. 82:2911-2914.
Davenport et al.. 1968. Lack of adjuvant effect of AIPO on purified influenza virus hemagglutinins in man..J Immunol. 100(5):1139-40.
Fiorini et al.. 1985.Bacillus subtillisselectively stimulates the synthesis of membrane bpoound and secreted IgA.Chemoterapia. 4: 310-312.
Fujihashi et al. 2000. Mucosal vacination and immune responses in the elderly. Vacine 18: 1675-1680.
Glezen et al. 1999. Maternal immunization.Clin Infect DisFeb;28(2):219-24.
Green et al. SM. 1999. Characterization ofBacillusspecies used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.Appl. Environ. Microbiol. 65:4288-89.
Hoa et al. 2000. Characterization ofBacillusspecies used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.Appl. Environ. Microbiol. 66: 5241-47.
Hodge et al.. 2001. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization.Infect ImmunApril, 69(4):2328-38.
Houba et al.. 1992. Protodyne: an immunostimulatory protein component, prepared from gram-positiveBacillus subtilis. Dev. Biol. Stand. 77: 1211-28.
Hinmanen et al. 1993. Biological activities of lipoteichoic acid and peptidoglycan-tichoic acid ofB. subtilis168 9Marburg).J. Gen. Microbiol. 139:2659-2665.
Johnen et al. 2001. Long-term tumour growth suppression in mice immunized with naked DNA of the human tumour antigen mucin (MUCi).Cancer Immunol. Immunother. 50:356-360.
Kaliński et al. 1999. T-cell priming by type-i and type-2 polarized dendritic cells: the concept of a third signal.Immunol TodayDecember;20(12):561-7.
Langenkamp et al. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells.Nat Immunol. (4):311-16.
Lyden et al. 2001. The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2.J Immunol166(6):3882-89.
Maidak et al. 2000. The RDP (Ribosomal Database Project) continues.Nucleic Acids Res, 28(1): 173-74.
Malkiel et al. 1971. The adjuvant activity of bacillus subtilis and subtiliis.J. Allergy.Clin. Immunol. 48:220-223.
Manning et al. 2001. CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice.Exp. Geront. 37:107-126.
Mishell B.B. and Shiigi S.M. eds. 1980. Selected methods in cellular immunology. W.H. Freeman and Company, New York., pp. 3-5.
Mazza P. 1994. The use ofBacillus subtilisas an anti-diarrhoeal microorganism.Boll. Chim. Farm. 133:3-18.
Morelli et al..2001. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligationBlood., 98(5):1512-23.
Nagao et al. 2001. Elevated levels and different repertoire profile of colostral anti-LPS antibodies may have a significant role in compensating newborn immunity.Scand J Immunol53(6):602-9.
Okoko et al. 2001. The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population.Trop Med lnt HealthJul. 2001;6(7):529-34.
Parissi-Crivelli et al. 2000. Recognition of enteropathogenicEscherichia colivirulence determinants by human colostrum and serum antibodies.J Clin Microbiol38(7):2696-700.
Rappuoli et al. 1999. Structure and mucosal adjuvanticity of cholera andEscherichia coliheat-labile enterotoxins,Immunology Today20:493-499.
Reis e Sousa et al.. 1997. In vivo microbial stimulationinduces rapid CD40 ligand-independent production of Interleukin 12 by dendritic cells and their residtribution to T cell areas.,J. Exp. Med. 186:1819-1829.
Senesi et al.. 2001. Molecular characterization and identification ofBacillus clausiistrains marketed for use in oral bacteriotheraphy.Appl. Environ. Microbiol. 67:834-839.
Sneath, P.H.A. 1986. Endospore forming gram positive rods and cocci. Bergey's Manual of Systemic Bacteriology. (Ed. Holt J.G.) Williams and Wilkins. Baltimore. vol. 2, Section 13, 1130.
Spencer et al. 1996. Dysregulation of IL-10 production with aging: possible linkage to th ag
Barnes Andrew Graham Colin
Klaviniskis Linda Sylvia
DeWitt Ross & Stevens S.C.
King's College London
Leone, Esq. Joseph T.
Minnifield N. M
LandOfFree
Composition and corresponding method of using spores of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and corresponding method of using spores of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and corresponding method of using spores of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4058860